IME Stock Overview
About the company
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA.I, a set of artificial intelligence tools in the cloud that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. The company was incorporated in 2001 and is based in Mascot, Australia.
Capture your thoughts, links and company narrative
ImExHS Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.49|
|52 Week High||AU$0.92|
|52 Week Low||AU$0.40|
|1 Month Change||16.67%|
|3 Month Change||6.52%|
|1 Year Change||-37.97%|
|3 Year Change||-45.56%|
|5 Year Change||n/a|
|Change since IPO||-63.70%|
Recent News & Updates
|IME||AU Healthcare Services||AU Market|
Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 16.2% over the past year.
Return vs Market: IME underperformed the Australian Market which returned -8.9% over the past year.
|IME Average Weekly Movement||9.8%|
|Healthcare Services Industry Average Movement||10.1%|
|Market Average Movement||8.3%|
|10% most volatile stocks in AU Market||14.5%|
|10% least volatile stocks in AU Market||3.6%|
Stable Share Price: IME is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: IME's weekly volatility (10%) has been stable over the past year.
ImExHS Limited Fundamentals Summary
|IME fundamental statistics|
Is IME overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IME income statement (TTM)|
|Cost of Revenue||AU$10.14m|
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.074|
|Net Profit Margin||-17.62%|
How did IME perform over the long term?See historical performance and comparison